Skip to main content

Table 2 RANKL, OPG and CD4+ T cell count in overall cohort

From: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults

WEEK sRANKL sOPG RANKL/OPG ratio CD4 + T cells
week 0 7.79 (2.83–12.01) (n = 48) 34.19 (26.53–45.75) (n = 48) 0.21 (0.08–0.36) 200 (86–280) (n = 48)
week 12 8.03 (3.72–11.01) (n = 45) 40.52 (28.55–53.67) (n = 45) 0.18 (0.11–0.30) 300 (202–400) (n = 48)
week 24 5.75 (2.88–9.41) (n = 45) 35.83 (25.54–50.66) (n = 45) 0.17 (0.07–0.29) 340 (240–470) (n = 47)
week 48 5.92 (3.07–11.98) (n = 43) 36.10 (26.19–55.82) (n = 42) 0.16 (0.09–0.35) 360 (250–535) (n = 45)
week 96 6.03 (1.02–11.31) (n = 34) 38.24 (29.82–50.47) (n = 33) 0.15 (0.05–0.30) 450 (280–600) (n = 43)
  1. Values are depicted as median and interquartile range (IQR). sRANKL and OPG in picograms/ml (pg/ml) and CD4+ T cells as cells/μl